PreVista

The Future of Ophthalmic Diagnostic Screening

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Newton, MA, USA
  • Currency USD
  • Founded March 2020
  • Employees 3
  • Incorporation Type S-corp
  • Website http://cornea project.com

Company Summary

General ophthalmic practice screening:
PreVista provides early detection of KC
Corneal crosslinking for KC is third party reimbursed
General ophthalmology practices are acquiring KC crosslinking capability because it generates superb practice revenue
General ophthalmologists will do better professionally & financially with PreVista POC KC diagnostic capability
PreVista POC users will be seen as leaders in best practices

Advisors

  • Kathryn Hatch
    Unconfirmed
    Dr. Vance Thomson
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free